US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Oncology Therapeutics, Inc

6.76

-2.1050-23.76%

Pre-market: 6.800.0459+0.68%04:26 EDT

Volume:1.50M

Turnover:10.70M

Market Cap:540.32M

PE:-2.97

High:8.86

Open:8.86

Low:6.30

Close:8.86

52wk High:14.87

52wk Low:6.30

Shares:79.99M

Float Shares:35.75M

Volume Ratio:9.42

T/O Rate:4.19%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.2730

EPS(LYR):-4.3039

ROE:-81.92%

ROA:-47.10%

PB:1.67

PE(LYR):-1.57

Loading ...

Overview Company News Filings

BridgeBio Oncology Therapeutics (BBOT) Receives a Buy from Wedbush

BridgeBio Oncology Thera Price Target Maintained with a $25.00/Share by Wedbush

BridgeBio Oncology price target lowered to $20 from $23 at Canaccord

BridgeBio Oncology Therapeutics Inc : Stifel Cuts Target Price to $15 from $23

THOMSON REUTERS

U.S. Research Roundup-Argan, Mastec, Oracle

BBOT Reports BBO-8520 Data in NSCLC, Highlights Combination Results

MT Newswires Live

BridgeBio Oncology Therapeutics Releases RAS-Pathway Therapeutics Corporate Update Deck

BridgeBio Oncology Therapeutics - Bbo-8520 Monotherapy Shows 63% Orr, 100% Dcr in 2L+ Krasg12c Nsclc

THOMSON REUTERS

BridgeBio Oncology Therapeutics - Bbo-11818 and Bbo-10203 Monotherapy Data Update Expected in Q4 2026

THOMSON REUTERS

Bbot Announces New Bbo-8520 Data; Highlights Strategic Focus on 2L+ Nsclc Bbo-8520 Combination as Well as Bbo-11818 and Bbo-10203 Combinations in Kras-Mutant Cancers

THOMSON REUTERS

BridgeBio Oncology Therapeutics - Expanded Bbo-8520 Plus Pembrolizumab Dataset Expected in Mid-2027

THOMSON REUTERS

BridgeBio Oncology Therapeutics - May Offer up to $500 Mln in Securities - SEC Filing

THOMSON REUTERS

BBOT to Participate in Upcoming Investor Healthcare Conferences

BridgeBio Oncology Therapeutics (BBOT) Receives a New Rating from Wedbush

Analysts Offer Insights on Healthcare Companies: 908 Devices (MASS), Pediatrix Medical Group (MD) and BridgeBio Oncology Therapeutics (BBOT)

BridgeBio Oncology Therapeutics Beri Opsi Saham 65.350 Lembar Kepada Dua Karyawan Baru Dengan Harga Pelaksanaan USD 9,28

BridgeBio Oncology Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BridgeBio Oncology Q2 EPS $(705.20) Misses $(0.57) Estimate

Benzinga Earnings

BridgeBio Oncology Net Loss Widens 98,94% to USD 56,5 Juta in Q2 FY26

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BBOT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBOT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBOT\",,,,,undefined,":{"symbol":"BBOT","market":"US","secType":"STK","nameCN":"BridgeBio Oncology Therapeutics, Inc","latestPrice":6.755,"timestamp":1788984000000,"preClose":8.86,"halted":0,"volume":1499708,"hourTrading":{"tag":"盘前","latestPrice":6.8009,"preClose":6.755,"latestTime":"04:26 EDT","volume":142,"amount":976.608976,"timestamp":1789028797659,"change":0.0459,"changeRate":0.006795,"amplitude":0.000133},"delay":0,"changeRate":-0.23758465011286678,"floatShares":35752400,"shares":79988687,"eps":-2.273,"marketStatus":"Pre-Mkt","change":-2.105,"latestTime":"09-10 04:51:45 EDT","open":8.86,"high":8.86,"low":6.295,"amount":10704806.97517,"amplitude":0.289503,"askPrice":7.5,"askSize":100,"bidPrice":6.75,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-2.273,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789047000000},"marketStatusCode":1,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":6.755,"preHourTrading":{"tag":"盘前","latestPrice":6.8009,"preClose":6.755,"latestTime":"04:26 EDT","volume":142,"amount":976.608976,"timestamp":1789028797659,"change":0.0459,"changeRate":0.006795,"amplitude":0.000133},"postHourTrading":{"tag":"盘后","latestPrice":6.8699,"preClose":6.755,"latestTime":"19:54 EDT","volume":19300,"amount":130531.3958,"timestamp":1788998073258,"change":0.1149,"changeRate":0.01701,"amplitude":0.066617},"volumeRatio":9.420879989289032},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBOT\",,,,,undefined,":{"symbol":"BBOT","floatShares":35752400,"roa":"-47.10%","roe":"-81.92%","lyrEps":-4.3039,"volumeRatio":9.420879989289032,"shares":79988687,"dividePrice":0,"high":8.86,"amplitude":0.289503,"preClose":8.86,"low":6.295,"week52Low":6.295,"pbRate":"1.67","week52High":14.87,"institutionHeld":0,"latestPrice":6.755,"committee":-0.818182,"eps":-2.273,"divideRate":0,"volume":1499708,"delay":0,"ttmEps":-2.273,"open":8.86,"prevYearClose":12.52,"prevWeekClose":8.98,"prevMonthClose":8.8,"prevQuarterClose":7.62,"fiveDayClose":8.82,"twentyDayClose":9.2,"sixtyDayClose":7.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBOT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"BBOT","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-05-12","symbol":"BBOT","fiscalQuarterEnding":"2026/03","expectedEps":-0.51,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.53},{"market":"US","date":"2026-03-05","symbol":"BBOT","fiscalQuarterEnding":"2025/12","expectedEps":-0.67,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-11-12","symbol":"BBOT","fiscalQuarterEnding":"2025/09","expectedEps":-0.41,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.03},{"market":"US","date":"2025-08-01","symbol":"BBOT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754020800000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBOT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBOT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3636,"buy":0.6364,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6364,"analysts":11,"updateTime":1783569600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBOT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBOT","date":"2026-09-09","current":-2.971843,"percent":0.965909,"low":-11.944957,"twenty":-9.597462,"median":-7.043047,"eighty":-4.419647,"high":-3.70137,"avg":-7.037497,"sd":2.530977,"marketCap":710344005},"quantilePoints":[{"date":"2025-08-22","current":-9.544109,"twenty":-10.820609,"median":-9.81087,"eighty":-9.532253,"marketCap":835109579},{"date":"2025-08-29","current":-9.336629,"twenty":-9.787158,"median":-9.514469,"eighty":-9.277349,"marketCap":816955023},{"date":"2025-09-05","current":-9.959071,"twenty":-9.864223,"median":-9.514469,"eighty":-9.247708,"marketCap":871418691},{"date":"2025-09-12","current":-10.047991,"twenty":-10.065775,"median":-9.65773,"eighty":-9.388005,"marketCap":879199215},{"date":"2025-09-19","current":-10.690193,"twenty":-10.20212,"median":-9.78123,"eighty":-9.467045,"marketCap":935391888},{"date":"2025-09-26","current":-11.678196,"twenty":-11.017222,"median":-9.944251,"eighty":-9.487793,"marketCap":1021842155},{"date":"2025-10-03","current":-11.259509,"twenty":-11.190123,"median":-10.077631,"eighty":-9.526325,"marketCap":985207072},{"date":"2025-10-10","current":-11.196152,"twenty":-11.224546,"median":-10.323455,"eighty":-9.563869,"marketCap":979663302},{"date":"2025-10-17","current":-10.3182,"twenty":-11.192532,"median":-10.372506,"eighty":-9.601414,"marketCap":902842494},{"date":"2025-10-24","current":-9.838494,"twenty":-11.156298,"median":-10.223893,"eighty":-9.601414,"marketCap":860868237},{"date":"2025-10-31","current":-10.861263,"twenty":-11.08659,"median":-10.23674,"eighty":-9.656742,"marketCap":950360520},{"date":"2025-11-07","current":-11.087539,"twenty":-11.118284,"median":-10.345353,"eighty":-9.745662,"marketCap":970159697},{"date":"2025-11-14","current":-11.205203,"twenty":-11.201583,"median":-10.472068,"eighty":-9.804136,"marketCap":980455269},{"date":"2025-11-21","current":-8.47671,"twenty":-11.192532,"median":-10.345353,"eighty":-9.572151,"marketCap":974262207},{"date":"2025-11-28","current":-8.567184,"twenty":-11.17443,"median":-10.251046,"eighty":-9.478901,"marketCap":984660736},{"date":"2025-12-05","current":-8.0313,"twenty":-11.121014,"median":-10.182434,"eighty":-9.298176,"marketCap":923069447},{"date":"2025-12-12","current":-8.936039,"twenty":-11.105583,"median":-10.084778,"eighty":-9.061365,"marketCap":1027054741},{"date":"2025-12-19","current":-8.389716,"twenty":-11.080298,"median":-9.97426,"eighty":-8.826299,"marketCap":964263621},{"date":"2025-12-26","current":-8.490629,"twenty":-11.051335,"median":-9.938056,"eighty":-8.720294,"marketCap":975861981},{"date":"2026-01-02","current":-8.713334,"twenty":-11.00789,"median":-9.919954,"eighty":-8.650698,"marketCap":1001458361},{"date":"2026-01-09","current":-9.256178,"twenty":-10.960825,"median":-9.809862,"eighty":-8.597806,"marketCap":1063849537},{"date":"2026-01-16","current":-8.003462,"twenty":-10.901088,"median":-9.61327,"eighty":-8.567184,"marketCap":919869900},{"date":"2026-01-23","current":-7.829474,"twenty":-10.885701,"median":-9.557912,"eighty":-8.530995,"marketCap":899872728},{"date":"2026-01-30","current":-8.699415,"twenty":-10.880305,"median":-9.521034,"eighty":-8.553265,"marketCap":999858587},{"date":"2026-02-06","current":-7.063925,"twenty":-10.867923,"median":-9.470009,"eighty":-8.485061,"marketCap":811885173},{"date":"2026-02-13","current":-7.947786,"twenty":-10.83411,"median":-9.398729,"eighty":-8.38554,"marketCap":913470805},{"date":"2026-02-20","current":-7.043047,"twenty":-10.812388,"median":-9.272371,"eighty":-8.35979,"marketCap":809485512},{"date":"2026-02-27","current":-7.13352,"twenty":-10.763512,"median":-9.179623,"eighty":-8.144045,"marketCap":819884041},{"date":"2026-03-06","current":-6.882977,"twenty":-10.695084,"median":-9.036987,"eighty":-8.006246,"marketCap":791088114},{"date":"2026-03-13","current":-5.451193,"twenty":-10.678337,"median":-8.936039,"eighty":-7.945698,"marketCap":730699673},{"date":"2026-03-20","current":-5.403428,"twenty":-10.588779,"median":-8.821207,"eighty":-7.854528,"marketCap":724297048},{"date":"2026-03-27","current":-5.510899,"twenty":-10.477499,"median":-8.762051,"eighty":-7.489849,"marketCap":738702956},{"date":"2026-04-02","current":-5.391486,"twenty":-10.453966,"median":-8.733947,"eighty":-7.421645,"marketCap":722696391},{"date":"2026-04-10","current":-5.287,"twenty":-10.379747,"median":-8.713334,"eighty":-7.088979,"marketCap":708690647},{"date":"2026-04-17","current":-5.504928,"twenty":-10.361645,"median":-8.657658,"eighty":-7.020776,"marketCap":737902628},{"date":"2026-04-24","current":-5.355662,"twenty":-10.30763,"median":-8.605462,"eighty":-6.799463,"marketCap":717894422},{"date":"2026-05-01","current":-5.021307,"twenty":-10.25963,"median":-8.567184,"eighty":-5.98855,"marketCap":673076041},{"date":"2026-05-08","current":-4.692922,"twenty":-10.225879,"median":-8.553265,"eighty":-5.587323,"marketCap":629057988},{"date":"2026-05-15","current":-4.419866,"twenty":-10.182434,"median":-8.490629,"eighty":-5.506122,"marketCap":681079323},{"date":"2026-05-22","current":-4.73149,"twenty":-10.167401,"median":-8.47671,"eighty":-5.429101,"marketCap":729099017},{"date":"2026-05-29","current":-4.595521,"twenty":-10.107271,"median":-8.403635,"eighty":-5.355662,"marketCap":708146799},{"date":"2026-06-05","current":-4.278409,"twenty":-10.091924,"median":-8.379277,"eighty":-5.319839,"marketCap":659281465},{"date":"2026-06-12","current":-3.878121,"twenty":-10.077631,"median":-8.309681,"eighty":-5.287,"marketCap":597598995},{"date":"2026-06-18","current":-3.992489,"twenty":-10.053919,"median":-8.201809,"eighty":-5.246997,"marketCap":615222558},{"date":"2026-06-26","current":-3.997687,"twenty":-9.989006,"median":-8.066098,"eighty":-5.177737,"marketCap":616023629},{"date":"2026-07-02","current":-4.054871,"twenty":-9.965147,"median":-8.010422,"eighty":-5.018919,"marketCap":624835411},{"date":"2026-07-10","current":-4.725485,"twenty":-9.946462,"median":-7.965184,"eighty":-4.959212,"marketCap":728173575},{"date":"2026-07-17","current":-4.319998,"twenty":-9.932881,"median":-7.944306,"eighty":-4.729088,"marketCap":665690034},{"date":"2026-07-24","current":-4.533138,"twenty":-9.923745,"median":-7.895589,"eighty":-4.678698,"marketCap":698533946},{"date":"2026-07-31","current":-4.41877,"twenty":-9.900032,"median":-7.829474,"eighty":-4.589283,"marketCap":680910384},{"date":"2026-08-07","current":-4.56433,"twenty":-9.857488,"median":-7.544133,"eighty":-4.574377,"marketCap":703340373},{"date":"2026-08-14","current":-4.060031,"twenty":-9.815588,"median":-7.439739,"eighty":-4.568002,"marketCap":739388569},{"date":"2026-08-21","current":-3.997399,"twenty":-9.757518,"median":-7.182237,"eighty":-4.533138,"marketCap":727982344},{"date":"2026-08-28","current":-4.041423,"twenty":-9.678478,"median":-7.105682,"eighty":-4.446842,"marketCap":735999771},{"date":"2026-09-04","current":-3.918156,"twenty":-9.605366,"median":-7.063925,"eighty":-4.423586,"marketCap":713550976},{"date":"2026-09-09","current":-3.900546,"twenty":-9.597462,"median":-7.043047,"eighty":-4.419647,"marketCap":710344005}],"updateTime":1789030305852},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBOT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666531334","title":"BridgeBio Oncology Therapeutics (BBOT) Receives a Buy from Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2666531334","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666531334?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:05","pubTimestamp":1788966328,"startTime":"0","endTime":"0","summary":"In a report released today, from Wedbush maintained a Buy rating on BridgeBio Oncology Therapeutics, with a price target of $25.00. The word on The...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bridgebio-oncology-therapeutics-bbot-receives-a-buy-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bridgebio-oncology-therapeutics-bbot-receives-a-buy-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBOT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533589","title":"BridgeBio Oncology Thera Price Target Maintained with a $25.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533589","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533589?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:30","pubTimestamp":1788957000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBOT/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBOT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666223587","title":"BridgeBio Oncology price target lowered to $20 from $23 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2666223587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666223587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:16","pubTimestamp":1788952602,"startTime":"0","endTime":"0","summary":"Canaccord lowered the firm’s price target on BridgeBio Oncology (BBOT) to $20 from $23 and keeps a Buy rating on the shares. The firm updated its m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bridgebio-oncology-price-target-lowered-to-20-from-23-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bridgebio-oncology-price-target-lowered-to-20-from-23-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587668","title":"BridgeBio Oncology Therapeutics Inc : Stifel Cuts Target Price to $15 from $23","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587668?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:07","pubTimestamp":1788952068,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN4510R0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666300172","title":"U.S. Research Roundup-Argan, Mastec, Oracle","url":"https://stock-news.laohu8.com/highlight/detail?id=2666300172","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666300172?lang=en_us&edition=fundamental","pubTime":"2026-09-09 14:55","pubTimestamp":1788936930,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Argan, Mastec, OracleSept 9 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Argan, Mastec and Oracle","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL4N4510GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADBG","APD","FLNC","CAI","AIRR","ANF","CRK","SMOG","AKTS","TXG","BETR","COLL","A","RTH","FSLR","TINY","ARMK","CVS","ASO","DYN","AGX","AEO","ARKG","BLTE","CLH","CC","BRZE","EVMN","ADBU","AMRZ","EXP","CTEC","BBWI","STYL","CHYM","CASY","ANIP","AMRX","FRNW","DKS","FIGR","AVTR","CRI","BRKR","ABM","IBAT","ADBE","DECK","BBOT","PLCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666704673","title":"BBOT Reports BBO-8520 Data in NSCLC, Highlights Combination Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2666704673","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666704673?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:29","pubTimestamp":1788902979,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics  said Tuesday BBO-8520 plus pembrolizumab showed a 75% objective response rate at 500 mg once daily and 53% across dose levels in KRASG12C inhibitor-experienced NSCLC patients.BBO-8520 monotherapy showed a 63% objective response rate and 100% disease control rate in second-line or later KRASG12C inhibitor-naive NSCLC patients. Of 28 patients eligible for six-month follow-up, 75% remained on treatment for more than six months.The company said BBO-8520 was generally tolerable and manageable, with no grade 3 liver enzyme elevations reported in the monotherapy cohort.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBOT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370612","title":"BridgeBio Oncology Therapeutics Releases RAS-Pathway Therapeutics Corporate Update Deck","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370612","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370612?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:11","pubTimestamp":1788901897,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics releases RAS-pathway therapeutics corporate update deckBridgebio Oncology Therapeutics released a corporate deck outlining three Phase 1 RAS-pathway programs with clini","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL6JmYWh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBIO","BK4505","BBOT","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666937206","title":"BridgeBio Oncology Therapeutics - Bbo-8520 Monotherapy Shows 63% Orr, 100% Dcr in 2L+ Krasg12c Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2666937206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666937206?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897935,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN4500Y7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBOT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666720633","title":"BridgeBio Oncology Therapeutics - Bbo-11818 and Bbo-10203 Monotherapy Data Update Expected in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666720633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666720633?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897935,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN4500Y7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666709372","title":"Bbot Announces New Bbo-8520 Data; Highlights Strategic Focus on 2L+ Nsclc Bbo-8520 Combination as Well as Bbo-11818 and Bbo-10203 Combinations in Kras-Mutant Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666709372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666709372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897935,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN4500Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBOT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372064","title":"BridgeBio Oncology Therapeutics - Expanded Bbo-8520 Plus Pembrolizumab Dataset Expected in Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372064","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372064?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897935,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN4500Y7:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBOT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664616798","title":"BridgeBio Oncology Therapeutics - May Offer up to $500 Mln in Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664616798","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664616798?lang=en_us&edition=fundamental","pubTime":"2026-09-02 05:16","pubTimestamp":1788297366,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0RG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886917","title":"BBOT to Participate in Upcoming Investor Healthcare Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886917","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886917?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:05","pubTimestamp":1788293100,"startTime":"0","endTime":"0","summary":"Investor Contact:. Investors@BBOTx.com. Media Contact:. Inizio Evoke Comms. Jake.robison@inizioevoke.com","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354587/0/en/bbot-to-participate-in-upcoming-investor-healthcare-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","BBOT","BK4588","BK4139","XLV","LABU","LU0029874061.USD","LU0128526141.USD","BK4585","HCSG","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658035829","title":"BridgeBio Oncology Therapeutics (BBOT) Receives a New Rating from Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2658035829","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658035829?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:55","pubTimestamp":1786542924,"startTime":"0","endTime":"0","summary":"Wedbush analyst initiated coverage with a Buy rating on BridgeBio Oncology Therapeutics today and set a price target of $25.00. In a report release...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bridgebio-oncology-therapeutics-bbot-receives-a-new-rating-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bridgebio-oncology-therapeutics-bbot-receives-a-new-rating-from-wedbush-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997785","title":"Analysts Offer Insights on Healthcare Companies: 908 Devices (MASS), Pediatrix Medical Group (MD) and BridgeBio Oncology Therapeutics (BBOT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997785?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:20","pubTimestamp":1786537240,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 908 Devices (MASS), Pediatrix Medical Group (MD) a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-908-devices-mass-pediatrix-medical-group-md-and-bridgebio-oncology-therapeutics-bbot-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-908-devices-mass-pediatrix-medical-group-md-and-bridgebio-oncology-therapeutics-bbot-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4196","BK4139","BK4157","XLV","LU0128526141.USD","HCSG","BK4588","LU0029874061.USD","MD","MASS","BK4585","LABU","XBI","BBOT","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658145945","title":"BridgeBio Oncology Therapeutics Beri Opsi Saham 65.350 Lembar Kepada Dua Karyawan Baru Dengan Harga Pelaksanaan USD 9,28","url":"https://stock-news.laohu8.com/highlight/detail?id=2658145945","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658145945?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:54","pubTimestamp":1786481656,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology Therapeutics beri opsi saham 65.350 lembar kepada dua karyawan baru dengan harga pelaksanaan USD 9,28Bridgebio Oncology Therapeutics memberikan opsi saham non-kualifikasi untuk tota","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL5l5hY9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","BK4585","BBIO","BBOT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945316","title":"BridgeBio Oncology Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945316","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945316?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:40","pubTimestamp":1786480800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA9LS1YX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBOT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658147945","title":"BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658147945","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658147945?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:40","pubTimestamp":1786480800,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Aug.  11, 2026  (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malign","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/11/3343195/0/en/bridgebio-oncology-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBOT","BK4539","LCLG","LENZ","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945387","title":"BridgeBio Oncology Q2 EPS $(705.20) Misses $(0.57) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945387","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945387?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:39","pubTimestamp":1786480750,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology (NASDAQ:BBOT) reported quarterly losses of $(705.20) per share which missed the analyst consensus estimate of $(0.57) by 123619.3 percent. This is a 24.49 percent decrease over losses of $(566.46) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61128346/bridgebio-oncology-q2-eps-705-20-misses-0-57-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BridgeBio Oncology Q2 EPS $(705.20) Misses $(0.57) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBOT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658943580","title":"BridgeBio Oncology Net Loss Widens 98,94% to USD 56,5 Juta in Q2 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2658943580","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658943580?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:15","pubTimestamp":1786479339,"startTime":"0","endTime":"0","summary":"BridgeBio Oncology net loss widens 98,94% to USD 56,5 juta in Q2 FY26Bridgebio Oncology Therapeutics membukukan rugi bersih kuartal II 2026 melebar menjadi USD 56,5 juta dari USD 28,4 juta setahun seb","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDLyc3Gz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BBOT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":63,"code":"91000000","status":"200"}]}}